|Videos|October 28, 2017

Dr Munoz-Price Calls for "Clear Delineation" of Role of Hospital Epidemiologist

Silvia Munoz-Price, MD, PhD, calls for a clear delineation of the role of hospital epidemiologists.

Silvia Munoz-Price, MD, PhD, Associate Professor of Clinical Medicine at the Institute for Health and Society, Medical College of Wisconsin, and Enterprise Epidemiologist for Froedtert & the Medical College of Wisconsin, calls for a clear delineation of the role of hospital epidemiologists.

Interview Transcript (slightly modified for readability):

"I think we are all a team in a hospital and in my own hospital I work very well within the quality department and within the nursing component of infection control department. But because we don’t have in-hospital epi, we don’t have a clear delineation of our role, and what is it that we do that other members of the team do[n't] do? I feel that that grey area at some point expands and makes our turf contract. So, that’s why I think a clear delineation of our role will be helpful so that we can continue working in more functional teams in the future."


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
ID Week Highlights Part 1
In this first IDWeek 2026 roundup, oral olorofim matched AmBisome in invasive aspergillosis, aztreonam-avibactam held activity as MBL-producing CRE rose, pritelivir cut hospitalizations in refractory HSV, and zelicapavir shortened RSV symptoms in high-risk adults.